We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Envista Holdings Corp (NVST) USD0.01

Sell:$18.96 Buy:$18.97 Change: $0.15 (0.80%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$18.96
Buy:$18.97
Change: $0.15 (0.80%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$18.96
Buy:$18.97
Change: $0.15 (0.80%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Contact details

Address:
200 S. Kraemer Blvd., Bldg. E
BREA
92821
United States
Telephone:
+1 (714) 8175418
Website:
https://envistaco.com/en

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NVST
ISIN:
US29415F1049
Market cap:
$3.24 billion
Shares in issue:
172.10 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Paul Keel
    President, Chief Executive Officer, Director
  • Eric Hammes
    Chief Financial Officer
  • Veronica Acurio
    President - Orthodontics
  • Robert Befidi
    President - Diagnostics
  • Stefan Nilsson
    President - Nobel Biocare
  • Mark Nance
    Senior Vice President, General Counsel, Secretary
  • Mischa Reis
    Senior Vice President - Strategy and Corporate Development

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.